Key facts
- Biophytis SA filed a Form 6K on June 2, 2024.
- Form 6K filings are typically used to disclose information to security holders.
Biophytis SA, a biopharmaceutical company, submitted a Form 6K filing to the U.S. Securities and Exchange Commission (SEC) on June 2, 2024. This type of filing is generally used by foreign private issuers to provide information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange.
